Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic Associated Steatotic Liver Disease”

177 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 177 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07313787
What this trial is testing

Effects of Meal Macronutrients on Postprandial Lipids

Who this might be right for
Nephrotic SyndromeLipodystrophyMetabolic Syndrome+3 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 100
Not applicableNot Yet RecruitingNCT07480811
What this trial is testing

The Effect of the DASH Diet on Clinical and Metabolic Parameters in Children With MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Antalya Training and Research Hospital 88
Large-scale testing (Phase 3)Active Not RecruitingNCT06161571
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
NASH/MASHNAFLD/MASLD
Akero Therapeutics, Inc 700
Not applicableNot Yet RecruitingNCT07530419
What this trial is testing

Samsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseFatty LiverLiver Fibrosis
Seoul National University Hospital 95
Not applicableNot Yet RecruitingNCT07373769
What this trial is testing

Ultrasound Liver Imaging for Classification of Metabolic Dysfunction-associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
University of British Columbia 145
Not applicableLooking for participantsNCT07330830
What this trial is testing

Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (AdipoDROMExpo)

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Centre Hospitalier Universitaire de la Guadeloupe 600
Not applicableLooking for participantsNCT07270601
What this trial is testing

Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseNAFLD - Non-Alcoholic Fatty Liver Disease
ContextVision AB 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT07024212
What this trial is testing

Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects

Who this might be right for
MASLD
Zhejiang Doer Biologics Co., Ltd. 110
Not applicableStudy completedNCT07095010
What this trial is testing

Lifestyle Habits and Metabolic Dysfunction-Associated Steatotic Liver Disease in Youth

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseChildhood Obesity
Harokopio University 224
Not applicableNot Yet RecruitingNCT07087041
What this trial is testing

Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests

Who this might be right for
Decompensated CirrhosisHepatitis B Virus (HBV) InfectionMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)+3 more
Beijing Friendship Hospital 735
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07193927
What this trial is testing

Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseFatty Liver Disease, NonalcoholicOverweight (BMI > 25)
AB Biotics, SA 60
Not applicableEnrolling By InvitationNCT06826807
What this trial is testing

Hepatic Elastography-Enhanced Lifestyle Modification in MASLD

Who this might be right for
Transient ElastographyMASLDBMI+4 more
Mahidol University 92
Not applicableUnknownNCT06154096
What this trial is testing

Liver Fat and Glucagon Resistance

Who this might be right for
Steatosis of Liver
Imperial College London 20
Not applicableEnrolling By InvitationNCT06994871
What this trial is testing

Effects of Different Exercises on Intrahepatic Lipid in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 186
Not applicableNot Yet RecruitingNCT07305324
What this trial is testing

Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI

Who this might be right for
MASLDFibrosis of Liver
Yale University 40
Not applicableStudy completedNCT06352697
What this trial is testing

Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults MASLD Patients (DELI_MASLD Study)

Who this might be right for
Metabolic Dysfunction Associated Steatotic Liver DiseaseSteatotic Liver DiseaseHepatic Steatosis
Bogomolets National Medical University 50
Not applicableLooking for participantsNCT06735924
What this trial is testing

Influence of Metabolic Syndrome on Endogenous Oxalate Synthesis

Who this might be right for
MASLDMetabolic Dysfunction-Associated Steatotic Liver Disease
University of Alabama at Birmingham 28
Not applicableEnrolling By InvitationNCT07001865
What this trial is testing

Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolically Healthy ObesityHyperuricemia
Ningbo No. 1 Hospital 17,040
Not applicableNot Yet RecruitingNCT07032311
What this trial is testing

Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk

Who this might be right for
Type 2 DiabetesPrediabetesLiver Disease
SIPPA Solutions INC 200
Not applicableStudy completedNCT06647095
What this trial is testing

New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Who this might be right for
HealthySimple Steatosis (SS)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)+1 more
General University Hospital, Prague 172
Load More Results